< Back to latest news & events

Event

IQPC Life Science IP 2019 – London

November 2019

Event date: 26th November 2019

HGF are sponsoring IQPC Life Science IP conference on 26-27 November in London with Partner Martyn Fish, Legal Director Michelle Davies and Partner Rachel Fetches attending.

Life Science IP 2019 will include a range of subjects around practical strategies for navigating the regulatory landscape and maximising the value of IP within Life Science, whilst sharing practical knowledge with speakers and colleagues.

Martyn Fish will be chairing day 1 and will be joining a panel debate ‘Alternative Means of IP Protection’.

He will be discussing ‘What alternative forms of protection to patent protection exist for the pharmaceutical industry: Can gene sequences be protected by copyright? Developments in the drug names? Design Right in chemical structures?’

  • Trade secrets
  • Trade marks – GSK’s Seretide inhaler
  • Copyright
  • Designs – claiming infringement for the copy of medicine designs.

Michelle Davies will be presenting on day 1 ‘Legal Risk Mitigation & Minimisation Across your Business’:

Issues across the business are inevitable, from the inadvertent disclosure of sensitive information through to adverse event reporting, patient interactions, manufacturing problems or product recall. Whilst some risks can be avoided, it is often the inappropriate handling of situations and panic responses made by a business that can cause the greatest damage.

Steps can be taken as a matter of good business practice to prevent or minimise business risk and exposure. With twelve years’ experience supporting business teams and functions within the pharmaceutical industry, Michelle will discuss her insights and the practical steps she deems most effective.

Latest updates

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

INTA 2025 Annual Meeting Live

The HGF European team will be attending the INTA Annual Meeting Live, which will take place on 17th-21st May in San Diego, US. The conference will connect some of the …

Read article

HGF wins big at the Managing IP EMEA Awards Ceremony 2025

The Annual Managing IP Awards: EMEA Awards 2025 were announced last night, and HGF are proud to have won 7 awards. The Managing IP Awards are highly recognised and respected …

Read article

Plant Patent Infringement in the US Relies on Evidence of Asexual Reproduction

A recent case in the US District Court for the Northern District of Texas (Dallas Division) once again highlights how important the initial pleadings and evidence in patent infringement cases …

Read article

Exam Success at HGF!

HGF is pleased to announce that several of our attorneys have passed their UK Advanced Patent exams! In no specific order, we would like to say well done and a …

Read article

IP Ingredients: How food companies are using IP to stay ahead of the GLP-1 curve

The impact of GLP-1 on the food and beverage sector GLP-1 agonists, best-known under the brand names Ozempic® and Wegovy®, are medicines used to treat type 2 diabetes and obesity. …

Read article

European Innovation Remains Strong: The EPO Patent Index 2024

The Patent Index 2024, recently published by the European Patent Office (EPO), provides a rich dataset from which key patent trends can be identified. The data shows that demand for …

Read article